UMIN-CTR Clinical Trial

Recruitment status Recruiting
Unique ID issued by UMIN UMIN000021399
Receipt No. R000024681
Official scientific title of the study Efficacy of fecal microbiota transplantation in patients with inflammatory bowel disease
Date of disclosure of the study information 2016/04/01
Last modified on 2016/10/16 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Efficacy of fecal microbiota transplantation in patients with inflammatory bowel disease
Title of the study (Brief title) Efficacy of fecal microbiota transplantation in patients with inflammatory bowel disease
Region
Japan

Condition
Condition inflammatory bowel disease
Classification by specialty
Gastroenterology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To assess the efficacy of fecal microbiota transplantation in patients with inflammatory bowel disease
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes To assess the rate of remission induction of patients treated with fecal microbiota transplantation
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 fecal microbiota transplantation
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
15 years-old <=
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria Patients who are diagnosed as mild - moderate inflammatory bowel disease (ulcerative colitis, crohn disease, bechet disease) at our hospital and refractory to standard treatments
Key exclusion criteria Patients with severe inflammatory bowel disease, those who are considered inappropriate by physicians, or those who do not agree with entering the study.
Target sample size 10

Research contact person
Name of lead principal investigator Toshiharu Sakurai
Organization Kinki university
Division name Gastroenterology
Address 377-2 Ohno-higashi Osaka-sayama
TEL 072-366-0221
Email sakurai@med.kindai.ac.jp

Public contact
Name of contact person Toshiharu Sakurai
Organization Kinki university
Division name Gastroenterology
Address 377-2 Ohno-higashi Osaka-sayama
TEL 072-366-0221
Homepage URL
Email sakurai@med.kindai.ac.jp

Sponsor
Institute Kinki university
Institute
Department

Funding Source
Organization Kinki university
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 04 Month 01 Day

Progress
Recruitment status Recruiting
Date of protocol fixation
2016 Year 03 Month 08 Day
Anticipated trial start date
2016 Year 04 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 03 Month 08 Day
Last modified on
2016 Year 10 Month 16 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024681